glp 1 agonist diabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Upcoming wave of hormone-based therapies
Description
The active ingredient in semaglutide GLP-1 injections is a type of GLP-1 receptor agonist
Tirzepatide is the first in a class of drugs called dual GLP-1/GIP receptor agonists that activate the receptor for another gut hormone, glucose-dependent insulinotropic polypeptide (GIP), in addition to the GLP-1 receptor
a Metered Dose Inhaler (MDI), i.e
Nature Reviews Clinical Oncology, 14 , 8599
Dual agonists that activate both GLP-1 and GIP receptors tend to cause these side effects slightly more frequently than pure GLP-1 agonists
C., Mallory, J., & Home, P
